Robert G. Uzzo MD, MBA, FACSDeputy Chief Clinical Office and Director, Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman, Department of Surgical Oncology, Fox Chase Cancer Center; G. Willing “Wing” Pepper Professor of Urological Oncology, Fox Chase Cancer Center/Temple University; Chair, Fox Chase/Einstein Urologic Institute, Philadelphia, Pennsylvania
Dr. Uzzo graduated summa cum laude from Union College and attended Cornell University Medical College. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.
Dr. Uzzo is currently the Deputy Chief Clinical Officer; Director of Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman of the Department of Surgical Oncology, Fox Chase Cancer Center; and the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute. He maintains an active, funded laboratory investigating kidney and prostate cancer. His clinical interests include minimally invasive urological oncology and renal malignancies. He has authored over 300 peer-reviewed articles in urologic oncology.
Recent Contributions to PracticeUpdate:
- Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy
- Comparison of Partial vs Radical Nephrectomy Effect on Other-Cause Mortality, Cancer-Specific Mortality, and 30-Day Mortality in Patients Older Than 75 Years
- Outcomes and Healthcare Costs of Robotic-Assisted vs Laparoscopic Radical Nephrectomy
- Cost Effectiveness in RCC—What Is Value and Who Gets to Decide?
- Growth Kinetics of Small Renal Masses on Active Surveillance
- Natural History, Predictors, and Management of Ureteroenteric Strictures After Robot-Assisted Radical Cystectomy
- Surgical Histopathology for Suspected Oncocytoma on Renal Mass Biopsy
- Percutaneous Renal Biopsies for Small Renal Masses: Complex Tumors on Nephrometry Should Be the First Targets
- Atezolizumab Adjuvant Study: Urologist Perspective
- Renal Mass Biopsy: Always, Sometimes, or Never?